Cunningham et al., 2008 - Google Patents
Induction of c-Fos and ΔFosB immunoreactivity in rat brain by vagal nerve stimulationCunningham et al., 2008
View HTML- Document ID
- 7948194282856993269
- Author
- Cunningham J
- Mifflin S
- Gould G
- Frazer A
- Publication year
- Publication venue
- Neuropsychopharmacology
External Links
Snippet
Vagus nerve stimulation (VNS) is used as therapy for treatment-resistant depression or epilepsy. This study used immunohistochemistry for biomarkers of short-term (c-Fos) and long-term (ΔFosB) neuronal activation to map regions in brain that are activated by acute (2 …
- 230000000638 stimulation 0 title abstract description 79
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation, e.g. heart pace-makers
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation, e.g. heart pace-makers
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/36025—External stimulators, e.g. with patch electrodes for treating a mental or cerebral condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/40—Detecting, measuring or recording for evaluating the nervous system
- A61B5/4076—Diagnosing or monitoring particular conditions of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/04—Detecting, measuring or recording bioelectric signals of the body of parts thereof
- A61B5/0476—Electroencephalography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Cunningham et al. | Induction of c-Fos and ΔFosB immunoreactivity in rat brain by vagal nerve stimulation | |
| Carmi et al. | Efficacy and safety of deep transcranial magnetic stimulation for obsessive-compulsive disorder: a prospective multicenter randomized double-blind placebo-controlled trial | |
| Potts | Inhibitory neurotransmission in the nucleus tractus solitarii: implications for baroreflex resetting during exercise | |
| Steininger et al. | Subregional organization of preoptic area/anterior hypothalamic projections to arousal‐related monoaminergic cell groups | |
| Devilbiss et al. | Corticotropin-releasing factor acting at the locus coeruleus disrupts thalamic and cortical sensory-evoked responses | |
| Vonck et al. | The mechanism of action of vagus nerve stimulation for refractory epilepsy: the current status | |
| Boissard et al. | The rat ponto‐medullary network responsible for paradoxical sleep onset and maintenance: a combined microinjection and functional neuroanatomical study | |
| Lane et al. | Respiratory neuroplasticity and cervical spinal cord injury: translational perspectives | |
| Furlong et al. | The effect of air puff stress on c‐Fos expression in rat hypothalamus and brainstem: central circuitry mediating sympathoexcitation and baroreflex resetting | |
| Ter Horst et al. | Trigeminal nociception-induced cerebral Fos expression in the conscious rat | |
| Yamakawa et al. | The cholinergic forebrain arousal system acts directly on the circadian pacemaker | |
| Vila-Pueyo et al. | Brain structure and function related to headache: Brainstem structure and function in headache | |
| Hamani et al. | Deep brain stimulation in clinical trials and animal models of depression | |
| Langevin | The amygdala as a target for behavior surgery | |
| Bari et al. | Brain imaging correlates of peripheral nerve stimulation | |
| Vergallito et al. | Effectiveness of noninvasive brain stimulation in the treatment of anxiety disorders: a meta-analysis of sham or behaviour-controlled studies | |
| Fournier‐Gosselin et al. | Regional anatomy of the pedunculopontine nucleus: relevance for deep brain stimulation | |
| Tjen-A-Looi et al. | Modulation of cardiopulmonary depressor reflex in nucleus ambiguus by electroacupuncture: roles of opioids and γ-aminobutyric acid | |
| Cole et al. | Evidence supporting deep brain stimulation of the medial septum in the treatment of temporal lobe epilepsy | |
| Ross et al. | Deep brain stimulation in the central nucleus of the amygdala decreases ‘wanting’and ‘liking’of food rewards | |
| Di Hou et al. | A systematic review of TMS and neurophysiological biometrics in patients with schizophrenia | |
| Gernert et al. | Subregional changes in discharge rate, pattern, and drug sensitivity of putative GABAergic nigral neurons in the kindling model of epilepsy | |
| Trifilio et al. | Impact of transcutaneous vagus nerve stimulation on healthy cognitive and brain aging | |
| Gurel et al. | Effect of transcutaneous cervical vagus nerve stimulation on the pituitary adenylate cyclase-activating polypeptide (PACAP) response to stress: A randomized, sham controlled, double blind pilot study | |
| Ito | Visceral region in the rat primary somatosensory cortex identified by vagal evoked potential |